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D uring the interval from 15 to 2y2 
months ago, 45 patients were treated at the 
University of Colorado Medical Center with 
renal homografts obtained from living vol- 
unteer donors. As a consequence of this 
experience, many aspects of renal homo- 
transplantation have come into focus, in- 
cluding the early41 and late39, 40 behavior of 
homografts, the events and reversibility of 
rejection,39, 40 the importance of technical 
factors in both donorz2 and 
operations in obtaining good early renal 
function, the influence of blood type incom- 
patibility upon results,41, 43 and the value of 
variant techniques for the treatment of 
infants and children.44 
Despite the fact that the majority of pa- 
tients survived operation and are presently 
in good health, there has been a persistently 
high mortality which has tended to occur in 
certain types of cases under recurrently 
similar circumstances. In  this paper, an at- 
tempt will be made to analyze the factors 
which seemed to have had a demonstrable 
influence on the outcome of renal honlo- 
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transplantation. Furthermore, the mecha- 
nisms that caused death will be documented 
in the unsuccessful cases, and suggestions 
made for changes in management which 
may, in the future, help avoid the previously 
encountered lethal complications. 
Finally, note will be made of several un- 
usual clinical syndromes which have been 
observed after renal homotransplantation, 
including the apparent development of host 
tolerance to specific strains of pathogenic 
bacteria, the appearance of unexplained 
fever or diffuse pulmonary disease late in 
the course of recovery; the coexistence of 
eosinophilia and fever in cases of atypical 
rejection, and the demonstration of physio- 
logic events during rejection which suggest 
the important role of a vascular lesion in 
causing functional deterioration at this time. 
METHODS 
The general techniques described by 
Kiiss20 and Murray and Harrisonz8 were 
used for transplantation, with modifications 
of A transabdominal operation was 
employed for children.44 All 45 patients 
had sp lene~tomy,~~ usually at the same time 
as homotransplantation and bilateral ne- 
phre~tomy.~"ight of the early patients had 
preliminary thyn~ectomy,~~ a procedure 
which is of unproved value. The temperature 
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of all homografts was lowered during the 
period of ischemia either by total body hy- 
pothermia of the donor or by perfusion with 
chilled electrolyte solution immediately after 
removal.22, 43 
The immunosuppressive reg imen,  as 
adapted from that of Calne and Murray and 
their  associate^,^-^^ 2 9 9  30 was previously de- 
40 Whenever possible, the adminis- 
tration of azathioprine was begun 8 to 10 
days before operation and used indefinitely 
thereafter. Azathioprine was thus employed 
in a fundamentally different way than other 
agents described below, in that it was used 
continuously rather than in response to spe- 
cific indications of rejection. Furthermore, 
it has not been discontinued in any case. 
With the onset of rejection, an event 
which was observed in 42 of the 45 patients, 
therapy with the use of daily doses of pred- 
nisone and intermittent doses of actinomy- 
cin C was begun.39 In  3 patients already 
receiving small quantities of prednisone, the 
doses were increased. After reversal of the 
rejection crisis, actinomycin C was discon- 
tinued, and the doses of prednisone were 
reduced as rapidly as possible. 
From the beginning of azathioprine 
therapy, close scrutiny was accorded the 
hematologic picture. White counts were ob- 
tained on each day during hospitalization. 
Although the white blood counts gave no 
indication of the effectiveness of azathioprine 
in the prevention or the treatment of rejec- 
tion, they provided an index of the toxicity 
of the drug and a direct, clear warning of 
overdosage. From the beginning, the dose 
was fixed at whatever level was possible 
without causing leukopenia. 
Total body irradiation was used in only 
one case.40 Local irradiation of the homo- 
graft was employed in 4 cases as described 
subsequently, with the use of the general 
technique outlined by Hume.17 
Numerous aspects of postoperative care 
are of vital importance in the avoidance of 
troublesome or lethal complications, but will 
not be described further here. These include 
the management of the acute postoperative 
diuresis,4*> 42 careful bacteriologic control of 
all antibiotic 34 and vigorous sup- 
portive treatment (including postoperative 
dialysis if necessary) of the hypertension, 
fluid and sodium retention, and electrolyte 
abnormalities which accompany a rejection 
RESULTS 
Survival statistics. Of the 45 patients, 27 
are alive on Feb. 12, 1964. The average post- 
operative interval is 190.9 days, with a range 
of 70 to 448 days. Fifteen cases have been 
followed for 6 months or longer, and 3 for 
more than a year. All but one patient is 
living at  home; the only exception is a 6- 
year-old child who suffered a cerebrovascu- 
lar accident in December, 1963, and who 
Table I. E f e c t  of consanguinity 
1"' 1 No. of 1 No. of 
Types of graft cases suruiuals deaths 
Mother-to-son* 8 6 2 
Mother-to-daughter 5 5 0 
Father-to-daughter 2 1 1 
Brother-to-brother?" 10 6 4 
Brother-to-sister 1 0 1 
Sister-to-brother* 6 4 2 
Unrelated 
Same sex* 8 3 5 
Female-to-male 4 1 3 
Male-to-female 1 1 0 
Total 45 27 18 
*In each group, 1 additional homograft was donated and 
removed either immediately or early in the postoperative 
course. The failures were due either to breeches of ABO 
incompatibility ( 2  cases) or to the imposition of exces- 
sive ischemia ( 2  cases). Second homografts were placed, 
and, in the above tabulation, only the final donors are 
considered. 
?Includes 2 sets of fraternal twins. One patient is alive 
after more than a year. The other died of a fungus brain 
abscess and gastrointestinal hemorrhage after 208 days. 
Table 11. Influence of age on  survival 
Nonre- 
Age in 1 No. of 1 luted 1 No. of 1 No. of 
years patients donors survivals deaths 
Total 45 13 27 18 
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Table 111. Blood groups of donors and 
recipients. ( I n  the 4 patients receiving 
2 homografts, only the second or 
definitizie donor is tabulated) 
7' 1 N o .  of N o .  
Blood t ype  cases survivals deaths 
Type 0 recipient* with: 
Related 0 donor 12 9 3 
Unrelated 0 donor 5 4 1 
Related A donor 1 1 0 
Type A recipient with: 
Related A donor 13 7 6 
Unrelated A donor 4 1 3 
Related 0 donor 3 2 1 
Unrelated 0 donor 2 0 2 
Related B donor 1 1 0 
Type B recipient with: 
Related B donor 1 1 0 
Unrelated 0 donor 1 1 0 
Type AB recipient with: 
Unrelated AB donor 1 0 1 
Unrelated A donor 1 0 1 
Total 45 27 18 
"In 2 of these 0 recipients, A and B homografts were 
placed. 111e transplants were destroyed immediately after 
~evascularization by an  apparent hemagglutinative pro- 
ccss, removed, and second homografts from 0 donors 
placed 10 and 14 days later.41 
Table IV. Influence of pretreatment wi th  
arathioprine upon  posttransplant longevity 
in  dogs* 
M e a n  
survival 1 N o  1 days I.0. 1 I./. 
Control animals, 21 , 10.8 2.75 .06 
untreated 
Animals started on 21 36 13.7 3.0 
azathioprine on 
day of operation 
Animals pretreated 18 69.1 68.1 16.1 
with azathioprine 
"Comparison of groups 2 and 3 ( p  < ,001). 
has since remained semicomatose. He has 
good renal function 200 days following 
operation. 
For the 18 patients treated unsuccessfully 
there was an average survival of 58 days, 
ranging from 1 to 208 days. Only 2 patients 
who lived for 3 months or longer subsequent- 
ly died, both of late septic complications at  
113 and 208 days. Their courses will be more 
carefully considered below. 
Effect of consanguinity. Mother-to-off- 
spring donations have been most successful 
(Table I ) ;  11 of 13 such patients are now 
alive 84 to 448 days after operation (average 
174.6 days). The only deaths were of 21- 
and 25-year-old sons who succumbed of 
pneumonia 48 days postoperatively, and of 
disseminated tuberculosis after 38 days, re- 
spectively. 
Two father-to-daughter homografts were 
performed. The first patient died of an 
electrolyte imbalance during a massive post- 
operative diuresis. The second is well after 
3 months. 
There were 17 sibling donations with 7 
- 
deaths; 6 of these cases were female-to-male 
transfers and 1, male-to-female (Table I ) .  
The surviving patients have been followed 
from 70 to 380 days (average 227.7 days). 
Poor results were obtained when the 
donors were not related to the recipients. 
Only 5 of 13 such patients are alive; the 
survivals ranged from 124 to 276 days 
(average 175.2 days). In the unsuccessful 
cases, the patients lived from 10 to 113 days 
postoperatively (average 55.5 days). 
Influence of age. Eighteen of 26 patients 
who were 34 years of age or younger are 
alive. Of 19 patients who were 35 years of 
age or older, only 9 are alive. Such statistics 
are, of course, heavily weighted by the fact 
that more than half of the latter group 
received kidneys from donors not related 
genetically (Table 11). Nevertheless, the 
incidence of nonrenal complications was 
much higher in the older recipients and con- 
tributed to the attrition as has been recently 
described.42 Postoperative complications in- 
cluded gastrointestinal hemorrhages, pan- 
creatitis, ileus, neurologic disorders, myo- 
cardial infarction, peripheral venous throm- 
bosis, and pulmonary embolization. 
Considerations of blood type. In  previous 
communications, general suggestions were 
formulated concerning the combinations of 
donor and recipient blood group incom- 
patibilities which were and were not 
safe.41> 43 Briefly, it appeared that the direc- 
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tion of permissible tissue transfer follows the 
same rules as those which apply to the 
emergency use of mismatched blood in that 
type 0 is the universal tissue donor and type 
AB the universal recipient. Subsequent ex- 
perience has tended to confirm these con- 
clusions. When combinations have been 
selected which do not place renal tissue in 
contact with preformed host hemaggluti- 
nins, immediate good renal function has 
always been observed and the late results 
have not been significantly different from 
those of the groups with donor-recipient 
ABO identity (Table 111). That such dicta 
were not absolute is evident (Table 111) 
from the fact that an A patient who received 
a kidney from a B donor and an 0 recipient 
who received a kidney from an A donor 
have good renal function at 12% and 6% 
months, respectively. Nevertheless, violations 
BUN 
mgm 96 
URINE VOLUME 
cc/day 
PREDNISONE 
mgm/day 
W I 
-10 0 10 20 30 4 0  
PRE OP DAYS &POST OP OAYS TIME IN DAYS 
Fig. 1. Typical case treated unsuccessfully. The kidney was ob- 
tained from the patient's brother; both of them were of A+ blood 
type. Good renal function postoperatively was interrupted by a 
violent rejection crisis after 12 days and anuria developed. After 
2 weeks of renal shutdown, secondary diuresis occurred. The 
patient died from drug toxicity, leukopenia, and septicemia 
(Table V, Case 32) .  Exceptionally vigorous rejection episodes 
seemed more common in recipients of blood type A than in those 
of other blood types. Note use of hemodialysis during height of 
rejection crisis. Acti C: each arrow represents the intravenous ad- 
ministration of 200 gamma actinomycin C. 
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of this general scheme resulted in the loss 
of 2 homografts immediately after their 
revascularization and this was apparently 
caused by the acute hemagglutination re- 
a c t i o n ~ . ~ ~  
Within the larger categories of patients 
who had identical donor-recipient ABO 
blood types, there was a subtler difference 
in late results which warrants description 
but which is of unknown significance. I n  
17 homotransplants of kidneys from A 
donors to A recipients, there were 9 deaths, 
a failure rate which was exorbitantly high 
with the use of both related and unrelated 
donors ('Table 111). In contrast, there were 
only 4 deaths in the comparable series of 
17 patients with 0 blood type (Table 111). 
I n  both groups, excellent early homograft 
function was obtained but the subsequent 
rejection episodes in A-type matches tended 
to be more severe and protracted (Fig. I ) ,  
suggesting that a specific sensitization to the 
red cell antigens, which have been demon- 
Distribution of Lymph Follicles 
Fig. 2. Theoretical considerations in the use of 
adjuvant thymectomy and splenectomy for the 
conditioning of recipient patients. The concept of 
the function of the thymus as an organizer in 
establishing fetal and neonatal immunologic re- 
activity is based largely on the work of Mil le~- ,~~s 26 
and may have no relevance in the adult animal. 
The role of the spleen in controlling response to 
antigenic stimuli in adult life is suggested by the 
work of Wissler and his colleagues.12~ 46 The con- 
tribution of these ancillary procedures to homo- 
graft survival is highly speculative at present. 
strated within renal cells,16, 45 may have OC- 
curred and contributed to the difficulty of 
maintaining homograft viability. Slight dif- 
ferences in the blood substance of the A 
donor and recipient, which are commonly 
present despite the absence of agglutination 
with direct cross-mat~hing,'~ could presum- 
ably lead to the delayed production of 
hemagglutinins and other circulating anti- 
bodies. Further observations will be neces- 
sary before it can be determined whether 
the difficulties in transplanting kidneys from 
A donors to A recipients are renal or whether 
they are due to coincidence. An interinstitu- 
tional cooperative study would be of great 
value in quickly arriving at a statistically 
significant conclusion. 
Excision of lymphoid masses. Thymec- 
tomy was performed upon eight of the 
patients but not upon the other thirty-seven. 
Splenectomy was performed in all 45 cases, 
usually at the same time as bilateral ne- 
phrectomy in the recipient and homotrans- 
plantation. Despite strenuous efforts in the 
laboratory, it has been impossible to demon- 
strate a potentiated homograft survival in 
dogs after splenectomy, making the use of 
this adjuvant procedure entirely empirical. 
Despite this, continued use of splenectomy 
may be justified for several reasons. First, it 
is possible that removal of the spleen makes 
the use of larger doses of azathioprine 
feasible, as least early in the postoperative 
period, because of the consequent leukocy- 
tosis. Second, it has been demonstrated in 
other experimental settings that splenectomy 
results in definite reduction of antibody 
response to various intravenous antigens.15, 35 
Third, the animal experiments of Wissler 
and his associates12, 46 suggest that, in the 
adult stage, the spleen may assume a pre- 
ceptor role in the organization of total im- 
munologic response (Fig. 2) not dissimilar 
to that attributed to the thymus in neonatal 
life by Miller.25s26 Finally, Hume18 and 
Hamburger13 and their associates have re- 
ported late sequelae of hypersplenism in 
several which otherwise had been success- 
fully treated; this necessitated a delayed 
splenectomy. 
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Table V. Principal factors in deaths 
Subphrenic 
abscess, 
septicemia, 
pneumonia, 
mediastinitis 
Mediastinitis, 
septicemia 
Staphylococcus, 
Pseudomonas 
Patient 
no. 
Staphylococcus, 
Pseudomonas 
11 Cardiac arrest 
and thoracot- 
omy during 
transplantation 
79 
Age 
In transplant 
wound, 
septicemia 
None 
Drug 
toxicity* Organism Infection 
Died 
during 
rejection 
crisis 
Staphylococcus, 
Pseudomonas 
Died 
after 
rejection 
crisis 
62 Cause of death 
not found 
207 Gastrointestinal 
hemorrhage 
T i m e  
survival 
(days)  
Brain abscesses, 
septicemia 
Other  factors i n  
mortality 
Pseudomonas, 
Candida 
albicans, 
Candida krusei, 
Nocardia 
Staphylococcus, 
Pseudomonas, 
Proteus 
l l t  35 X X In  old nephrec- 
tomy wound 
83 Acute and 
chronic 
pancreatitis 
95 
None 
Pneumonia Pneumocystis 
carinii 
Candida 
stellatoidea, 
Escherichia 
coli 
Pseudomonas, 
Proteus 
Brain abscesses, 
pneumonia 
Septicemia 
None 1 Died during 
diuresis of 
electrolyte 
imbalance 
25 Jejunal necrosis, 
pancreatic 
abscess, pulmo- 
nary emboli 
18 
Septicemia, 
tuberculosis 
E. coli 
Micrococcus 
tuberculosis 
Septicemia Paracolon, E. 
coli, Proteus 
mira bilis 
Pseudomonas Pneumonia 15 Pulmonary 
embolus 
41 Myocarditis, 
pyelonephritis, 
septicemia 
Pneumonia, 
septicemia 
Pneumonia, 
pulmonary 
edema 
Disseminated 
tuberculosis, 
septicemia 
Candida albicans, 
E. coli 
Pseudomonas 
Unknown 
M .  tuberculosis, 
Enterococcus 
*Bone marrow depression. 
$Posttransplant dialysis required 1 or more times. 
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Fig. 3. Typical case treated successfully. The  patient received a 
kidney from his sister; both had type 0 blood. Fever, azotemia, 
hypertension, transplant wound tenderness, and proteinuria ac- 
companied the relative oliguria and the decline in creatinine 
clearance which are depicted graphically. The changes were all 
reversed with the addition of prednisone and actinomycin C to 
the regimen. Leukopenia did not develop. Note the diminution 
of urine sodium concentration which is almost always observed 
during rejection and the paradoxical effect of prednisone in 
restoration of sodium excretion. Bilateral nephrectomy and sple- 
nectomy were performed at  the same time as transplantation. 
Ac t i  C: each arrow represents 200 gamma actinomycin C given 
intravenously. 
Pretreatment with azathioprine. Recipi- 
ents are usually treated with 2 to 4 mg per 
kilogram azathioprine for 7 to 10 days pre- 
operatively. The rationale for this practice 
is based upon the 60 experiments on dogs 
summarized in Table IV, in which homo- 
transplantation and bilateral nephrectomy 
were performed. Untreated animals lived for 
10.8 f .06 (S.E.) days. Animals whose treat- 
ment with azathioprine started on the day 
of operation lived 36 i- 3.0 (S.E.) days. 
Animals which received treatment with 
azathioprine for 7 to 30 days preoperatively 
as well as postoperatively lived for 69 i- 16.1 
(S.E.) days. The difference between the 2 
groups that received azathioprine was highly 
significant ( p  < .001) . 
The stages of recovery. The events which 
typify the course of a successfully treated 
case have been previously described in 
detailm, 40  and will not be exhaustively 
treated here. Uninterrupted recovery is 
almost never seen with the therapeutic regi- 
men employed in the present study. Post- 
operatively, there is a period lasting from 1 
to 42 days during which good homograft 
function is present. At some time during 
convalescence, a rejection crisis has almost 
invariably supervened with systemic mani- 
festations of fever, hypertension, and 
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Fig. 4. Value of Hume's method of local irradiation17 in the treatment of 
severe rejection. The patient (A blood type) received a kidney from his 
sister (0 blood type). After good initial function, gross hematuria de- 
veloped, followed by anuria and other features of acute rejection. Wound 
tenderness, which was so extreme that urinary extravasation was feared, 
was largely relieved within an  hour after the first dose of 150 r and re- 
sumption of urine excretion followed within 24 hours. The subsequent 
course was uncomplicated. Despite the rapidity of onset of rejection, it 
was possible, with 4 hourly analyses of urine composition, to demonstrate 
the changes that are thought to illustrate an ischemic component of re- 
jection (see text and Fig. 3 ) .  Acti C: each arrow represents 200 gamma 
actinomycin C given intravenously. The conditions of x-ray therapy are 
described in the text. 
malaise; with local transplant wound tender- 
ness; and with manifold evidence of renal 
functional deterioration. The addition of 
large doses of prednisone and actinomycin 
C to pre-existing therapy with azathioprine 
results in reversal of these events in most 
cases (Fig. 3) .  Later in the course, the drugs 
added secondarily can be reduced or 
stopped; this lends support to the belief that 
a state of host-graft adaptation occurs 
promptly in those cases which can survive 
the attempt a t  graft r e p u d i a t i ~ n . ~ ~  Sub- 
sequent secondary rejection crises have been 
observed in only 2 patients. 
Rejection crises not only varied in time 
of onset as mentioned above, but in vigor. 
Impairment of homograft function has 
ranged from the development of asympto- 
matic azotemia to the onset of complete 
anuria (Figs. 1 and 4 ) ,  which has lasted for 
1 to 14 days before the beginning of a 
secondary diuresis. Recently, intermittent 
local irradiation has been given by the 
method of Hume17 to 4 patients who had 
violent rejection episodes and anuria, with 
the use of 150 r (a t  depth) every other day 
for 3 days (Fig. 4 ) .  The dose was delivered 
with a 250 kv. unit at 30 Ma., HVL 2.5 mm. 
Cu, with the use of a Thoraeus I1 filter a t  a 
skin distance of 70 cm. Output was 31.8 r 
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Fig. 5. Course of recovery in patient who did not have a classical rejection 
crisis. Evidence of an  immunologic reaction was present after the second 
postoperative week with eosinophilia and high fever-findings which ulti- 
mately resolved spontaneously. The kidney for homograft was provided by 
his brother, both donor and recipient being A- blood type. The  patient 
who was operated upon on July 5, 1963, continues to have normal renal 
function. 
per minute. Resumption of urine excretion 
occurred on 3 occasions within a few hours 
after the first treatment. Equally impressive 
was the almost immediate relief of exquisite 
tenderness in the transplant wound. 
Urine composition during rejection. In  
many patients, urinary constituents were 
serially measured before, during, and after 
a rejection episode. Similar changes were 
observed in almost all these cases. Sharp 
declines in sodium concentrations were most 
characteristic (Fig. 3 ) ;  they sometimes fell 
as low as 0 to 10 mEq. per liter despite a 
continuing although reduced urinary output. 
Chloride alterations tended to be similar. 
Potassium values were variable. Urea and 
especially creatinine concentrations usually 
rose. The effect of prednisone upon urine 
composition was paradoxical in that this 
drug, which ordinarily promotes salt reten- 
tion, reversed these changes and appeared 
to promote sodium excretion (Fig. 3 ) .  In 
one patient who had 3 distinct rejection 
episodes, such alterations were noted on all 
3 occasions. Even in those patients who had 
a sudden early rejection with profound 
oliguria or anuria, similar but more rapidly 
evolving changes have been documented (by 
Dr. David Ogden) with the analysis of 4 
hour urine aliquots. The marked salt reten- 
tion is undoubtedly an important factor in 
the development of the fluid retention and 
acute hypertension which are often seen at 
the time of reje~tion.~'  
These findings also provide inferential in- 
f o r m a t i o n concerning pathophysiologic 
mechanisms of rejection inasmuch as the 
alterations in water, electrolyte, and creati- 
nine excretion are similar to those which 
have been observed in experimental Gold- 
blatt procedures and which form the basis 
of the Howard7 and S t a m e ~ ~ ~  clinical tests 
for renal ischemia. I t  has been known for 
many years that canine kidneys which are 
rejected have diffuse vascular injury con- 
sisting of fibrinoid degeneration and intra- 
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mural edema collection in and between the 
layers of vessel walls, endothelial prolifera- 
tion, and infiltration with pyroninophilic 
mononuclear cells." The effect of such 
lesions upon renal blood flow is speculative, 
but it seems reasonable to believe that they 
may add an important element of secondary 
ischemia to the process of rejection in view 
of the above findings and because of the 
common presence of coincident secondary 
hype r t en~ ion~~  at  this time. The indictment 
of a vascular mechanism is consistent with 
the observation that some homografts which 
fail after initial good excretion do not show 
any evidence of cellular rejection (Fig. 9) ,  
and that others resume function after vary- 
ing periods of delayed anuria in a way not 
unlike that seen in recovery from acute 
tubular necrosis (Figs. 1 and 4) .  Of interest 
is the recent observation of Porter32 concern- 
ing chronic proliferative changes in blood 
W B C  
vessels of homografts from which specimens 
were taken for biopsy late in the postopera- 
tive period. I t  is not unlikely that such 
lesions are the delayed sequelae of earlier 
insults upon the vascular system of the 
transplanted kidney. 
Postoperative eosinophilia. Prednisone was 
administered during the postoperative period 
to 43 of the 45 patients, the 2 exceptions 
being patients who received kidneys from 
brothers and in whom a recognizable rejec- 
tion episode did not occur. In  both cases, 
eosinophilia (accounting for as much as 46 
percent of the total white count) was ob- 
served, beginning 32 and 18 days after 
operation and lasting for 55 and 38 days, 
respectively. There was no deterioration of 
renal function. One patient was completely 
asymptomatic. The other (Fig. 5 )  became 
febrile, and 2 wound re-explorations were 
performed because infection was suspected. 
PT. R.W. 
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Fig. 6.  Fatal course of Case No. 24, a blood type A recipient. The donor 
was a convict volunteer of the same blood type. Note the precipitate drop 
in the white blood count in the last 2 days of life, a which time thrombo- 
cytopenia also developed. The cause of death was septicemia. Each arrow 
represents 200 gamma actinomycin C. 
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Fig. 7. Demonstration of leukopenic and thrombocytopenic effect of actino- 
mycin C. Note evidence of sudden bone marrow depression after 5 day 
course during which a total of 1,200 gamma was administered. After dis- 
continuance of actinomycin C, i t  was possible to resume the previous dose 
schedule of azathioprine. 
Similar phenomena have recently been noted 
in a least 2 other  center^.^, l3 Inasmuch as 
the abnormal differential count was not 
accompanied by impairment of homograft 
function, the significance of the finding is 
not evident although it appears to have been 
an index of immunologic activity. I t  is 
probable that eosinophilia might be more 
commonly observed if it were not for the 
masking effect of the steroids which are 
used in most cases. 
Causes of death. In the following analysis 
of failures, the essential information is given 
in tabular form for each case (Table V).  In 
addition, an attempt has been made to iden- 
tify recurrent clinicopathologic patterns 
which defeated efforts at treatment in 18 of 
the first 45 patients. The principal emphasis 
in the following remarks will be upon the 
causes of death which were seen repeatedly. 
The most frequent cause of death was 
drug toxicity which occurred during the 
effort to treat a rejection crisis; 9 patients 
died of this. The clinical courses of 2 such 
patients are shown in Figs. 1 and 6. In all 
but one of the 9 cases, the homografts 
provided excellent immediate function. The 
vigor of the subsequent rejection process was 
frequently greater than usual. In  some in- 
stances, the disquieting occurrence of de- 
creasing urinary volume, falling creatinine 
clearance, and mounting azotemia provoked 
unwise increases in drug dosage to a danger- 
ous level. In  others cases however, the 
therapeutic regimen employed was not 
thought to be predictably excessive, even 
upon retrospective analysis. 
In such unsuccessfully managed cases, the 
acute renal failure that occurred during the 
rejection crisis was accompanied by acute 
leukopenia (Figs. 1 and 6) and often by 
thrombocytopenia as if the patient had 
undergone a sudden change in sensitivity to 
azathioprine. Within a few hours or a few 
days, elevation of temperature most always 
indicated the onset of inexorable deteriora- 
tion which usually terminated with fatal 
pneumonia or septicemia or both (Table V). 
Three patients on whom dialysis was per- 
formed when the white blood counts were 
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3,000 or lower developed septicemia almost 
immediately after treatment, and all died 
shortly thereafter. The infecting organisms 
in such cases are listed in Table V. 
There is also evidence that actinomycin 
C may contribute to bone marrow depres- 
sion. I t  has been said that this drug is effec- 
tive for reversal of rejection in the dose 
range used without causing leukopenia3; 
however such a sanguine attitude is not 
justified. I n  several cases, a distinct rapid 
leukopenic and thrombocytopenic response 
was observed. In one instance, the associa- 
tion of bone marrow depression with admin- 
istration of actinomycin C was unmistakable 
because this drug appeared against a back- 
ground of stable therapy with azathioprine 
(Fig. 7) .  
In a second group of 6 patients (Cases 4, 
7, 9, 19, 21, and 38), a rejection episode 
was successfully reversed; however, death oc- 
curred 48 to 208 days after operation (Table 
V).  In  several of these cases, the ultimately 
fatal complications were thought to have 
originated during treatment of the preced- 
ing rejection crisis. An example is shown 
in Fig. 8 of a 25-year-old man (Case 7) who 
received a homograft from his wife. A ure- 
teral fistula that occurred one week after 
operation required ureteral reimplantation. 
After the second operation, the wound ap- 
parently healed without infection. However, 
at the peak of the rejection crisis, fever and 
toxemia developed as a result of a peritrans- 
plant infection. The wound was widely 
drained. Staphylococcus aureus was found 
in the tissues, but there was no pus or other 
evidence of active cellular reaction against 
PT. JEH. 2 5 Y O .  0 RENALHOMOGRAFT STAPHYLOCOCCUS AUREUS 
PERlNEPHRlC ABSCESS 
EXPIRED 
7
TEMPERATURE 
DEGREES C 
ACTINOMYCIN-C 
I 
- 
METHlClLLlN 
OXAClLLlN + 0 
PENICILLIN-G * 
KANAMYCIN + I 
+ - COLlSTlN 
TIME IN DAYS 
Fig. 8. Course of Case No. 7. Fatal wound infection was first noted during 
late stages of the rejection crisis. Note that fever developed coincidentally 
with reversal of rejection and was uninfluenced by antibiotics or by surgi- 
cal drainage. Death was due to septicemia. The simultaneous occurrence 
of rejection reversal and the development of uncontrollable sepsis suggested 
that: loss of reactivity to bacterial and renal antigens may have occurred 
simultaneously. 
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Fig. 9. Homografts recovered at  early and late autopsy. A, Case No. 29, 8 days after opera- 
tion. Death was due to drug toxicity and septicemia that occurred after an early vigorous 
rejection with anuria. Note the evidence of acute tubular necrosis with necrotic and flattened 
tubular epithelium. Protein casts are evident. Mitosis is indicated by arrow. Cellular infiltrate 
is minimal. (Hematox~lin and eosin. x80; reduced 95.)  B, Case No. 38, 48 days after operation. 
A rejection episode had been successfully treated. Death was due to pneumonia. The kidney 
is essentially normal. (Hematoxylin and eosin. x80; reduced $4.) 
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the pathogenic organisms. The patient ulti- 
mately died of septicemia. Similarly, another 
patient (Case 4) died almost 4 months after 
transplantation from a subphrenic abscess 
which apparently had its inception at the 
time a laparotomy for intestinal obstruction 
was performed 3 months previously. 
Of particular interest were 2 cases (Table 
V)  in which death occurred 76 and 208 
days after operation. Recovery had seemed to 
be without serious incident, although both 
patients had headache, behavioral distur- 
bances, and unexplained neurologic dis- 
ability. Fungus abscesses of the brain and 
a mixed fungal and bacterial pneumonia 
were found at autopsy. These complications 
probably originated at the time rejection 
was reversed although they did not become 
evident until months later. 
Two other patients (Cases 19 and 38) 
died of a peculiar pneumonic process which 
is described more fully in the following sec- 
tion and which may be of immunologic 
rather than infectious etiology. 
Each of the other 3 deaths was exception- 
al and cannot be categorized with the two 
groups described above. One death (Case 
26) occurred during a massive postoperative 
diuresis as the result of electrolyte im- 
balance. A second patient (Case 8) died 
with good renal function 62 days after opera- 
tion. At autopsy, no cause for death was 
evident. Finally, a 45-year-old woman died 
83 days postoperatively of acute and chronic 
pancreatitis, a complication of steroid ther- 
apy that has been described clinically6 and 
which has been reproduced experimentally 
in anima1s.l 
The homografts a t  autopsy. The speci- 
mens were reviewed by Dr. K. A. Porter of 
St. Mary's Hospital, London, and the follow- 
ing comments are based upon his prelimi- 
nary analysis as well as that of the University 
of Colorado Pathology Department. The 
general architecture of the homografts was 
comparably intact both in the patients who 
died at an early time (Fig. 9, A) and those 
who died later (Fig. 9, B),  although evi- 
dence of acute tubular damage was more 
common (Fig. 9, A) in the former group. 
Some cellular infiltrate was present in all but 
3 of the homografts, but this was not exten- 
sive in any case and was very minor in most. 
Blind reading of the sections did not permit 
ready separation of early from late speci- 
mens on the basis of anatomic findings. 
Chronic proliferative vascular lesions such 
as those described by Porter and his as- 
s o c i a t e ~ ~ ~  were extremely rare; they were 
identified, in fact, in only one instance (Case 
11). Porter, in reviewing all the pathologic 
material in this series, has, however, drawn 
our attention to the possible presence of 
more acute foci of fibrinoid degeneration in 
some of the arteries and arterioles which 
probably represents an early phase of the 
same process and one which in minimal form 
may heal without chronic stigmas. Porter 
has undertaken a detailed study of these 
more subtle changes in the homografts per- 
formed in Colorado employing special histo- 
chemical studies, and will report the findings 
at a later time. 
I t  is worth noting that he did find chronic 
proliferative arterial lesions in 2 of the 3 
cadaveric hon~ografts which were used at 
this institution, and which are not part of 
the present study. This observation raised 
the possibility that the development of an 
obliterative arteritis may be partially related 
to the degree of ischemia imposed upon the 
transferred tissue. Another possibility is that 
the differences in the prominence of such 
lesions in different centers may be a measure 
of the effectiveness of immunosuppressive 
therapy. 
Late noninfectious febrile syndromes. The 
hyperpyrexia that accompanies a frank re- 
jection crisis and which is almost immediate- 
ly controlled by the administration of pred- 
nisone has already been mentioned. I n  the 
absence of sepsis, fever does not subsequently 
return until the steroid quantities are at- 
tenuated to doses of 20 to 60 mg. per day, 
from 4 to 16 weeks later. I n  40 percent of 
the patients, the return of continuous high 
fever (103 to 105' F.) is observed at this 
time; it frequently starts just after the reduc- 
tion of prednisone from 45 to 30 mg. or 30 to 
20 mg. per day. I n  most cases, there is a pro- 
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Fig. 10. The appearance of nucleated red cells (normoblasts) in the pe- 
ripheral blood after transplantation to a 6-year-old child. The child was 
O+ blood type. The maternal donor was A+. Note the high ratio of normo- 
blasts to leukocytes. Drug dosages should be based upon the corrected 
rather than the falsely high peripheral count. Juvenile white cell forms are 
also frequently found a t  such times, although usually in smaller numbers. 
These changes are most marked in children, and are commonly associated 
with hyperpyrexia. 
tracted concomitant shower of peripheral 
normoblasts and other immature forms as 
depicted in Fig. 10. An exhaustive search 
for microbial complications is always con- 
ducted, but an explanation for the febrile 
illness is not usually found. With mainte- 
nance of the steroid dose at the new level, the 
hyperpyrexia has subsided without treatment 
in the usual case in 7 days to 4 weeks. Con- 
tinued withdrawal of steroids has thereafter 
been possible without further difficulty. 
In 6 exceptional patients, 3 of whom were 
children 3 to 8 years of age who were treated 
with homografts from adults, the late fever 
was associated with diffuse symmetrical 
bilateral pulmonary infiltrates which had a 
parahilar and lower lobar distribution (Fig. 
11). Five patients became cyanotic; arterial 
0, saturation was as low as 43 percent. 
Arterial pCO, was normal or slightly ele- 
vated. In each case, administration of nasal 
oxygen markedly increased arterial oxygen 
saturation. The condition of an 8-year-old 
child whose dose of prednisone had just been 
reduced to 20 mg. per day, was immediately 
made markedly worse with a further de- 
crease to 10 mg. per day for 2 days. Resump- 
tion of the original steroid regimen resulted 
in equally rapid improvement. 
The etiology of the pulmonary lesions is 
obscure. Elevated heterophil or cold agglu- 
tinin titers and suspicious cells on LE prepa- 
rations were each noted in one or more but 
not in all cases. The showers of peripheral 
normoblasts described above were present. 
One patient died of pulmonary insuffi- 
ciency. At postmortem, there was extensive 
consolidation of the lungs. Numerous intra- 
nuclear inclusion bodies were found in the 
alveolar lining walls. Other pathologic 
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features of this case were suggestive of 
Pneumocystis carinii. Nevertheless, the as- 
sociation of the infiltrates with steroid with- 
drawal, the improvement noted in one case 
with increased doses of prednisone, and the 
ultimate sudden disappearance of the ab- 
normalities in those patients who lived all 
suggest the possibility that the lesions have 
an immunologic rather than an infectious 
basis. I t  is possible that the death described 
above could have been prevented if the 
prednisone dose had been increased. 
DISCUSSION 
As has been made clear, the convalescence 
of patients who have received a renal homo- 
transplant is not an easy one. The events 
of rejection and the therapy necessary to 
prevent destruction of the homograft impose 
a period of great risk which lasts for several 
months after operation. I t  has been pointed 
out that patients receiving kidneys from 
familial donors have a greater chance of 
surviving this dangerous interval than those 
whose kidneys have come from genetically 
unrelated donors. 
Although there are differences in the risk 
to certain classes of recipients as noted in 
the present study, the steps to recovery are 
qualitatively similar in almost every case. 
The variations are only in degree. Thus, in 
maternal-to-offspring transplants, the crisis 
is usually temperate and more easily treated, 
but it is otherwise like that encountered with 
less favorable genetic combinations. In  all 
groups, moreover, most of the deaths and 
complications have either occurred in this 
early postoperative period or the events lead- 
ing to later morbidity or mortality have 
apparently had their inception at this time. 
I n  view of the intensity of the immunosup- 
pressive therapy necessa.ry for control and 
reversal of the rejection crisis, it is not 
difficult to appreciate the inherent danger 
of this phase of recovery. The fact that 
homograft function can be retained at all is 
perhaps the strongest indication of the ex- 
tent to which total body immunologic 
defenses have been weakened. In  addition, 
loss of reactivity to various test antigens,lg the 
inconstant development of hypogammaglob- 
~ l i n e m i a , ~ ~  and the appearance of steroid 
Fig. 11. Diffuse bilateral pulmonary infiltrates in a 20-year-old girl of A+ 
blood type who received a kidney homograft from a convict donor of 
the same blood group. Note rapid resolution of the extensive infiltrations 
which first appeared 2 months after operation. Transplantation was per- 
formed on Sept. 3, 1963. After the near fatal pulmonary complication, the 
subsequent convalescence was without complication. 
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HOST DEFENSE 
(peak at rajactnm cm3is) 
Fig. 12. Possible mechanism of simultaneous loss 
of host reactivity to specific strains of endogenous 
bacteria, and to the alien renal tissue. See text. 
diabetes are all indicators of the host's im- 
periled state. Rifkind33 has pointed out that 
isolation procedures are of limited value, 
since most infections noted during the re- 
jection crisis have originated from endoge- 
nous sources. 
Hope for long survival with the drug com- 
binations and the dosages used during the 
rejection crisis would be remote indeed if 
such stringent measures were permanently 
required for protection of the homograft. 
Fortunately, it has become increasingly 
clear, from various lines of evidence, that a 
state of homograft tolerance is an integral 
accompaniment of the successfully treated 
rejection crisis.14, 18, 2% 24, 319 47-49 I t  is poba-  
ble, however, that the development of toler- 
ance is a mixed blessing. I t  would be surpris- 
ing if immunologic memory for antigens 
other than those of the kidney was not also 
eliminated during reversal of the rejection 
crisis. Thus, pockets of pathogenic bacteria 
could flourish, unchecked by defenses which 
no longer recognize them as inimical (Fig. 
12) .  This concept has already received 
strong experimental support from the studies 
of Forsen and Condie.lo Examples have been 
cited in the present reports in which such a 
lethal chain of events has apparently oc- 
curred (Fig. 8). I t  will be of great practical 
as well as theoretical interest to determine, 
in future investigations, whether the com- 
monly observed complications caused by 
infections are due simply to the suppression 
of greatly weakened but balanced host 
defenses, or if there is the establishment of 
relatively specific clonal deficiencies which 
permit selective overgrowth of certain 
organisms. 
The aforementioned factors may be pres- 
ent to some degree in every case. Neverthe- 
less, it was commonly the additional com- 
ponents of bone marrow depression and 
leukopenia which appeared to precipitate 
the beginning of a fatal infection. Although 
all such cases must be classified as errors in 
the control of azathioprine dosage, it should 
be emphasized that the effect of this agent be- 
comes highly unpredictable in the presence of 
the poor renal function which accompanies 
a rejection crisis, possibly because azathio- 
prine has a partial renal pathway of detoxifi- 
~ a t i o n . ~  Whether this is the entire explana- 
tion is not certain, although it seems clear 
that the leukopenic effect of this drug is in- 
tensified at the time of acute renal failure. 
Thus, a patient with an unusually severe 
rejection crisis is most vulnerable to toxicity, 
despite the fact that this is the kind of case 
in which exact therapy with azathioprine is 
most needed. Consequently, the rejection 
crisis has often seemed to be the initiating 
influence in the genesis of fatal drug toxicity. 
I t  might be reasoned that aggressive dialysis 
therapy under such circumstances would be 
remediable. In  practice, however, the in- 
stitution of hemodialysis at this time has, on 
at least 3 occasions, seemed to be the direct 
cause of septicemia. 
Inasmuch as the greatest risk is during 
the period of rejection crisis, future attempts 
must be directed to improved management 
during this interval. I t  is probable that more 
specific pharmacologic agents will eventually 
become available. At present, attention will 
have to be focused upon more effective ma- 
nipulation of the existing agents. 
In  most of the 45 reported cases, it was 
attempted to use only one drug, azathi- 
oprine, in the early postoperative period, re- 
serving emergency administration of predni- 
sone and actinomycin C for the specific in- 
dications of rejection. There were several 
reasons for this practice. First, it was desi- 
rable to obtain information concerning the 
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efficacy of administering azathioprine with- 
out the superimposition of other pharmaco- 
logic factors. Second, the benefit of the 
secondary drugs could be assessed only in 
the situation in which primary therapy with 
azathioprine had already proved inadequate. 
Third, only by the graded use of drugs was 
it possible to demonstrate clearly the pres- 
ence and timing, first of rejection and then 
of adaptation. Fourth, it was not at first 
evident that adaptation would occur if 
efforts to prevent the rejection crisis were 
completely successful. Finally, the use of 
potentially dangerous doses of steroids for 
periods of time in the early convalescent 
phase when they did not appear to be 
needed, did not seem to be warranted. The 
last argument seemed especially pertinent 
inasmuch as the time of onset of the rejec- 
tion crisis was so variable, and because oc- 
casionally a patient did not require any 
treatment with steroids. 
I t  is evident that many of the most force- 
ful reasons for withholding steroid therapy 
until graft repudiation had clearly begun 
were for the purpose of delineating the fea- 
tures of rejection and adaptation, and de- 
fining the influence of drug therapy upon 
these processes. From a clinical point of 
view, this information is now nearly com- 
plete, as has been described in this and other 
 publication^.^^, 40  
I t  has now become desirable to test sys- 
tematically an alternative use of steroids, 
, employing prednisone prophylactically in 
the attempt either to  prevent altogether or 
to attenuate the rejection crisis. The 
potential advantages of this approach are 
clear. If profound renal failure could be 
prevented, the loss of predictability of the 
effect of azathioprine could be avoided, and 
it would be possible to use this agent more 
effectively. If mitigation of the rejection 
process can be demonstrated with this ap- 
proach, it is conceivable that the total 
steroid dose would also be lessened since 
reduction of the prednisone dose could be 
started at an earlier time. 
Based upon these considerations, the pro- 
tocol of management was changed at the 
University of Colorado Medical Center 
beginning Dec. 15, 1963. In addition to 
azathioprine, all recipients are now pre- 
treated for 2 days with 100 to 200 mg. 
prednisone, a dose which is continued into 
the immediate postoperative period. That 
the change may have merit has already been 
suggested by the studies of Hume,18 in which 
both the frequency and vigor of rejection 
episodes have seemed to be reduced with 
the employment of a combination of im- 
munosuppressive agents. I t  must be empha- 
sized that the value of this alteration in 
management is highly speculative at present, 
and that the demonstration of any benefit 
will have to wait further study. 
SUMMARY 
Forty-five patients were treated with renal 
homotransplantation 15 to 2% months ago. 
Twenty-seven are alive with adequate renal 
function after an average postoperative 
interval of 190.0 days. The other 18 died 
after an average period of 58 days. 
Several factors appeared to have in- 
fluenced the outcome; the most striking was 
the presence or absence of donor-recipient 
relationship. Best results were obtained in 
parent-to-offspring donations, next with 
sibling transfers, and poorest with transfers 
from genetically unrelated donors. Patients 
in the older age groups had a higher risk 
but this may have been partially due to an 
increased use of transfers from unrelated 
donors in such cases. Inexplicably, there ap- 
peared to be poorer results in recipients who 
had type A blood even when kidneys were 
from donors with the same blood type. 
The immunosuppressive regimen used for 
this series included adjuvant splenectomy 
and preoperative treatment with azathio- 
prine for 8 to 10 days. Direct evidence for 
the value of splenectomy is lacking and the 
rationale for its continued use is indirect. In 
contrast, the usefulness of pretreatment with 
azathioprine is supported by evidence from 
canine transplantation experiments. 
Most of the patients who were treated 
successfully passed through a rejection crisis 
at  which time the immunosuppressive 
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therapy was intensified. After the patients 
recovered from such episodes, the drug doses 
required for continued preservation of 
homograft function became less stringent, as 
if a state of homograft tolerance had been 
established. The preponderance of deaths 
either occurred during this period of maxi- 
mum immunosuppressive risk or at a later 
time as a result of complications which had 
originated during a rejection. Inferential 
evidence has been presented that some of 
the delayed lethal complications caused by 
infections may have been due to the develop- 
ment of clonal deficiencies to certain bac- 
terial antigens which resulted in later un- 
restrained growth of specific organisms. 
Since the events of rejection crises are 
the most important factors in causing 
mortality, alternative methods of immuno- 
suppression have been investigated which 
are designed to temper the vigor of the 
immunologic assault at  this time. For this 
purpose, the most significant alteration to 
be instituted in our study will be the use of 
prophylactic prednisone which will be 
started in the preoperative period. The value 
of this change in protocol is still highly 
speculative. 
Several new observations are recorded 
concerning delayed host reactions which 
occur after the immediate threat of rejection 
is past. These include the development of a 
delayed febrile syndrome during steroid 
withdrawal, which is often associated with 
diffuse pulmonary lesions and the appear- 
ance of abnormal peripheral blood smears. 
In  addition, physiologic data are presented 
which support the view that the rejection 
crisis has an ischemic factor as an important 
component. A pattern of deteriorating renal 
function can be identified in most patients 
during rejection which simulates that of a 
severe Goldblatt lesion. The effect is pre- 
sumably due to generalized hemodynamic 
alterations of the homograft vascular tree. 
That such alterations may be functional and 
reversible is suggested by the paucity, in 
homografts recovered in the postoperative 
period, of chronic proliferative vascular 
lesions such as those described by Porter. 
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DISCUSSION 
Dr. Keith Reemtsma (New Orleans, La.). 
During the past year our group a t  Tulane had 
difficulty obtaining suitable donor kidneys for 
transplantation. Our  attempts to  use cadaveric 
kidneys met with no significant success. The sup- 
ply of expended kidneys from neurosurgical cases 
was totally inadequate. We were reluctant to  use 
nonrelated volunteer humans, for ethical, medical, 
and legal reasons. 
As this impasse was approaching, we were pre- 
paring to enter the field of heterotransplantation. 
A regional primate center had been established 
in our vicinity and it attracted scientists experi- 
enced in various phases of primatology. Addition- 
ally, an active program in transplantation im- 
munology was being developed which gave an 
added base to the work. 
In our first clinical case, the kidneys from a 
rhesus monkey were used. They functioned for 7 
days and were removed 10 days after implanta- 
tion. The patient died in a uremic state. The 
specimen showed obstruction and necrosis of the 
distal ureters and moderate cellular infiltration 
of the kidneys. This case, of course, must be 
judged a failure, just as every previous clinical 
attempt reported in the literature was a failure. 
One month later, on Nov. 5, 1963, kidneys 
from a chimpanzee were implanted in a 43-year- 
old dock worker with terminal uremia who was 
maintained by dialysis. Immediate function was 
satisfactory, and 4 days later threatened rejec- 
tion occurred. This was reversed following radi- 
ation to the graft and increased doses of immuno- 
suppressive drugs. Evidence of graft function in- 
cluded serial renograms that showed normal up- 
take and disappearance of isotope over the graft 
and no evidence of function of the patient's kid- 
neys. Renal scans and intravenous urography con- 
firmed graft function. He left the hospital with 
normal renal function 7 weeks later but was re- 
admitted because of pneumonia. Despite treat- 
ment with antibiotics and reduction of immunosup- 
pressive measures he died 2 months after trans- 
plantation. Sections of the transplant showed 
tubular necrosis which was attributed to terminal 
shock, but there were none of the usual histologic 
findings typical of rejection. 
Five patients have been treated subsequently 
by a similar technique. Two of them survived, 
one with a functioning heterograft. Three of them 
died of infection with functioning heterografts, 
and in one patient the graft was removed be- 
cause function ceased. 
At this time it would be unwarranted to specu- 
late what role, if any, heterotransplantation will 
play in the future. Nevertheless, some encourage- 
ment may be derived from the case described 
above and from the subsequent cases in New Or- 
leans and Denver. The previous futile attitude 
toward heterografting must be modified in view 
of this evidence: such grafts may function satis- 
factorily for 2 months, the early graft-rejection 
process can be reversed, and the transplants do 
not show the usual stigmas of rejection. 
Until longer follow-up data are available, how- 
ever, this work must be considered wholly ex- 
perimental. Historic experience shows that the 
field of heterotransplantation may be flagrantly 
abused, and this work can be justified only if 
the strictest precautions are taken. But, in addi- 
tion to this heavy obligation, certain opportuni- 
ties, not feasible with homografts, now can be 
foreseen: extensive matching of donor and re- 
cipient, prolonged or strenuous pretreatment, and 
specific breeding programs for donors. 
Furthermore, we have the opportunity, as we 
enter this era of heterotransplantation, to  establish 
a new pattern of data processing. If standard 
forms adapted to computers are agreed upon, 
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these data may be coded rapidly, stored indefi- 
nitely, and retrieved instantaneously in any form 
desired. Such results forwarded at frequent inter- 
vals to a computer center, could then be made 
available a t  all times to any interested investiga- 
tor. Such rapid dissemination might reduce the 
need for an old method of learning: repeating 
each other's mistakes. 
Dr. John S. Najarian (San Francisco, Calif.). 
I think one of the intriguing things about Dr. 
Starzl's paper is the number of patients without 
cellular infiltration of the transplanted kidney 
who have had rejection or what appears to be 
rejection without any apparent morphologic 
change. 
We have seen a similar set of circumstances 
in the laboratory, specifically when we were 
working with a combination of mismatched blood 
groups in dogs. We have typed blood groups of 
dogs and then sensitized the dogs to blood group 
antigens. We sensitized the A-negative dogs to 
the A-1 red cell antigen, and even on adequate 
immunosuppression we saw a reaction very similar 
to that which Dr. Starzl has observed in his pa- 
tients: kidney homograft rejection proceeds with- 
out any cellular infiltration a t  all. Morphologi- 
cally these kidneys do not look bad, but they 
go into a very frank rejection; and only by rais- 
ing the level of the immunosuppressive drugs to 
the point where they are lethal can you over- 
come this particular occurrence. 
I am wondering if, in some of the mismatched 
donors, even in the minor groups, this may be 
contributing, in part, to the noncellular or humor- 
a1 type of rejection that Dr. Starzl and others 
have seen. 
We heard a week ago in New York, and have 
also confirmed in our laboratory, that you can 
reject homografted kidneys with serum factors 
alone, without any cells at  all, and get a similar 
morphologic response (work that was cited by 
Altman at that Homotransplantation Conference 
in New York). We have also observed one other 
thing, and I was interested to hear Dr. Starzl 
comment on this: that is, the eosinophilia that 
occurs in these patients. We have seen this quite 
frequently experimentally and in our clinical 
cases. Under these circumstances we have no good 
explanation for the eosinophilia, which actually 
rose to 48 percent of the total white count. 
Immunologically, we know that eosinophilia 
in this magnitude can represent antigen antibody 
complexes that we are sure are circulating in 
these circumstances, and these antigen antibody 
complexes may be due to minor red blood cell 
incompatibility types. This is the sort of thing 
that we are fighting. I think that one of the most 
intriguing things here is the noncellular rejection 
of the homograft, and I think more and more of 
us are going to see it. 
Dr. Stanley W. Jacob (Portland, Ore.). I 
want to ask Dr. Stan1 if he had any exact data 
on a particular question which has bothered me 
for some time. That is the question of the size 
of the smallest capillary in the heterografted kid- 
ney. Assuming we overcame the immune barrier, 
if we were dealing with a capillary size smaller 
than that in the human, this in itself might even- 
tuate in graft rejection. 
Dr. Starzl (closing). I am sorry to report to 
Dr. Jacob that we did not measure the size of 
the red cells in the baboons. 
The suggestion that information be pooled 
from different centers is a very attractive one. 
Shown here is one kind of data which illustrate 
the potential value of such an approach. 
(Slide.) Recently, both Hume's and our own 
group demonstrated that transplantation can be 
done under certain circumstances between donor 
and recipient patients of different blood types. 
Furthermore, those blood group combinations 
which can and cannot be mixed with relative 
safety were fairly well delineated. This slide shows 
a subtler influence, of blood grouping upon re- 
sults, in cases in which the donors and recipients 
were of the same ABO type. 
There were 17 patients of A blood type who 
received kidneys from donors who were also of A 
blood type. Of these 17, 9 are dead and 8 are 
alive. There was a n  almost identical group of 17 
patients of 0 blood type who received kidneys 
from 0 donors. In  the latter series, 13 are alive 
and only 4 dead. As you can see, good results 
with the 0 patients were obtained with the use of 
both genetically nonrelated as well as familial 
donors. 
We do not know the significance of this find- 
ing, but I think a pooling of interinstitutional 
data would quickly help resolve the question of 
whether or not the A patient occupies a rela- 
tively unfavorable position for transplantation. If 
this proves to be the case, the explanation, of 
course, may be something such as Dr. Najarian 
has alluded to. 
I enjoyed hearing Dr. Reemtsma's remarks 
concerning his experience with heterografts and 
would like to comment briefly on our experience 
employing baboons for the transplantations in 6 
patients. We were prompted to use this simian as 
a result of our knowledge of Dr. Claude Hitch- 
cock's previous temporarily successful attempt at 
baboon transplantation and by the advice and en- 
couragement provided by Dr. Reemtsma, who 
made all of his previously acquired experience 
available to us. Our  heterotransplantations were 
done in collaboration with Drs. Claude Hitch- 
cock, Bob Telander, and Lee Simso of the Minne- 
apolis General Hospital. 
The heterografts were used for patients who 
had been excluded from the living donor series, 
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either because of age or associated disease such 
as tuberculosis. The patients were operated upon 
from 2 months to 5 weeks ago. Three are still 
alive, 2 of whom have been discharged from the 
hospital. The renal function of the baboon trans- 
plant is poor compared with that obtained from 
the human homograft but it appears to be life 
sustaining on a short-term basis. Creatinine clear- 
ances in the 3 surviving patients range from 30 
to 65, and the blood urea nitrogen levels are 35 
to 100, as of last evening. The relatively poor 
function and the extremely heavy immunosup- 
pressive therapy necessary to prevent rejection 
are such serious problems at  the present time that 
we plan no more heterotransplants, at least with 
this particular subhuman primate. 
As of about the first of December we have 
altered our treatment protocol in an effort to 
focus therapeutically on the one phase of recovery 
that seems to account for most of the deaths; 
namely, the rejection crisis. Because of our suc- 
cess with the pretreatment regimen of azathio- 
prine, we are now embarked on a study in which 
prednisone pretreatment is being carried out in 
a comparable manner. 
